PARLIAMENTARY DEBATE
Antenatal Care: Vasa Praevia Screening - 11 February 2025 (Commons/Commons Chamber)

I thank my hon. Friend for his ongoing work in raising awareness in maternity services. We are committed to improving maternity care for women and babies. Evidence does not currently support screening for vasa praevia in the UK, but we have asked the Royal College of Obstetricians and Gynaecologists to review the guidance around this issue.

My constituent Cate Maddison suffered with severe vasa praevia in childbirth. This condition causes severe bleeding and can often result in the death of infants in childbirth and complications for the mother. However, the risks are significantly reduced when identified during pregnancy. Thankfully, Cate’s child survived, but she is campaigning to reduce unnecessary complications and deaths arising from the condition. Will the Minister meet me and Cate to discuss how we can tackle this important issue?

I am incredibly sorry to hear about Cate’s experience. We want to ensure that women receive safe, personalised and compassionate maternity care and that women with the condition are supported. That is why we have asked the college to look at the guidance. I will of course be happy to meet my hon. Friend and his constituent.

There is clearly a need to consider vasa praevia as part of antenatal care. The hon. Member for Crewe and Nantwich (Connor Naismith) set the scene very well and the Minister responded in a good fashion. This issue, which the hon. Member was right to highlight, is also an issue in Northern Ireland. Will the Minister share what is going forward here with representatives at the Northern Ireland Assembly?

I thank the hon. Member for that point. As he knows, I am always keen to ensure we share good practice across the United Kingdom so that his constituents, like mine, can benefit. We will work through the usual processes to ensure that happens.